DexCom Inc. (NASDAQ:DXCM) previous close was $405.10 while the outstanding shares total 96.30M. The firm has a beta of 0.77, a 12-month trailing P/E ratio
DexCom Inc. (NASDAQ:DXCM) has a beta of 0.75, a 12-month trailing P/E ratio of 71.24, and a growth ratio of 3.02. The stock’s Relative Strength
DexCom Inc. (NASDAQ:DXCM) has a beta of 0.77, a 12-month trailing P/E ratio of 68.41, and a growth ratio of 2.90. The stock’s Relative Strength
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
